BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 8742553)

  • 21. Multilevel models for hierarchically nested data: potential applications in substance abuse prevention research.
    Kreft IG
    NIDA Res Monogr; 1994; 142():140-83. PubMed ID: 9243536
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Project 1: longitudinal risk cohort study on the onset, course, prevalence and prevention of illegal drug abuse.
    Küfner H; Schumann J; Duwe A; Bühringer G
    Eur Addict Res; 1998 Dec; 4(4):205-6. PubMed ID: 10094598
    [No Abstract]   [Full Text] [Related]  

  • 23. Reducing substance use improves adolescents' school attendance.
    Engberg J; Morral AR
    Addiction; 2006 Dec; 101(12):1741-51. PubMed ID: 17156173
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use and misuse of repeated measures designs.
    Barcikowski RS; Robey RR
    NIDA Res Monogr; 1994; 142():302-41. PubMed ID: 9243540
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The developmental antecedents of illicit drug use: evidence from a 25-year longitudinal study.
    Fergusson DM; Boden JM; Horwood LJ
    Drug Alcohol Depend; 2008 Jul; 96(1-2):165-77. PubMed ID: 18423900
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis with missing data in drug prevention research.
    Graham JW; Hofer SM; Piccinin AM
    NIDA Res Monogr; 1994; 142():13-63. PubMed ID: 9243532
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessing the most powerful analysis method for school-based intervention studies with alcohol, tobacco, and other drug outcomes.
    Janega JB; Murray DM; Varnell SP; Blitstein JL; Birnbaum AS; Lytle LA
    Addict Behav; 2004 May; 29(3):595-606. PubMed ID: 15050677
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Examining the influence of drop-outs in a follow-up of maintained opiate users.
    Encrenaz G; Rondeau V; Messiah A; Auriacombe M
    Drug Alcohol Depend; 2005 Sep; 79(3):303-10. PubMed ID: 16102374
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Issues in classification in meta-analysis in substance abuse prevention research.
    Hansen WB; Rose LA
    NIDA Res Monogr; 1997; 170():183-201. PubMed ID: 9154258
    [No Abstract]   [Full Text] [Related]  

  • 30. Seven ways to increase power without increasing N.
    Hansen WB; Collins LM
    NIDA Res Monogr; 1994; 142():184-95. PubMed ID: 9243537
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drug prevention research with Native-American populations: some considerations.
    Powless Sage G
    NIDA Res Monogr; 1994; 139():235-48. PubMed ID: 8742559
    [No Abstract]   [Full Text] [Related]  

  • 32. Discussion: statistical analysis in treatment and prevention program evaluation.
    Ager JW
    NIDA Res Monogr; 1992; 117():31-40. PubMed ID: 1620204
    [No Abstract]   [Full Text] [Related]  

  • 33. Promoting measured genes and measured environments: on the importance of careful statistical analyses and biological relevance.
    Joober R; Sengupta S; Schmitz N
    Arch Gen Psychiatry; 2007 Mar; 64(3):377-8; author reply 378-9. PubMed ID: 17339527
    [No Abstract]   [Full Text] [Related]  

  • 34. Research design strategies to evaluate the impact of formulations on abuse liability.
    McColl S; Sellers EM
    Drug Alcohol Depend; 2006 Jun; 83 Suppl 1():S52-62. PubMed ID: 16554125
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is the receptivity of substance abuse prevention programming affected by students' perceptions of the instructor?
    Stephens PC; Sloboda Z; Grey S; Stephens R; Hammond A; Hawthorne R; Teasdale B; Williams J
    Health Educ Behav; 2009 Aug; 36(4):724-45. PubMed ID: 18809689
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effectiveness of Drug Abuse Resistance Education (project DARE): 5-year follow-up results.
    Clayton RR; Cattarello AM; Johnstone BM
    Prev Med; 1996; 25(3):307-18. PubMed ID: 8781009
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Latent class analysis of substance abuse patterns.
    Uebersax JS
    NIDA Res Monogr; 1994; 142():64-80. PubMed ID: 9243533
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug interactions in cocaine abuse: methodologic concerns in human and animal studies.
    Hyman SE; Zuckerman B
    Ann N Y Acad Sci; 1998 Jun; 846():69-75. PubMed ID: 9668398
    [No Abstract]   [Full Text] [Related]  

  • 39. Are there distinctive trajectory groups in substance abuse remission over 10 years? An application of the group-based modeling approach.
    Xie H; Drake R; McHugo G
    Adm Policy Ment Health; 2006 Jul; 33(4):423-32. PubMed ID: 16691463
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dynamic systems-modeling as a means to estimate community-based prevention effects.
    Kibel BM; Holder HD
    NIDA Res Monogr; 1994; 142():404-46. PubMed ID: 9243542
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.